THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.
This product is intended for in vitro laboratory research use only. All Information on this website is for educational purposes only.
This product is not a food, drug, or supplement and may not be misbranded, misused or mislabled as a food, drug, or supplement.
GW501516, also known as Cardarine or Endurobol, is a peroxisome proliferator-activated receptor delta (PPARδ) agonist. This compound has been extensively studied for its potential benefits in multiple areas. Below are some observed benefits from a research perspective:
-
Metabolic Disorders: GW501516 has shown potential in the treatment of metabolic disorders. Studies have demonstrated its potential for improving lipid profiles and increasing high-density lipoprotein (HDL) cholesterol which could be a valuable research area, especially concerning diseases like atherosclerosis and other heart diseases.
-
Athletic Performance: Research suggests GW501516 can enhance athletic performance by increasing endurance. Studies on mice models have shown an increased ability to run longer distances with its use. Understanding its mechanism may aid sports science research.
-
Fat Burning: GW501516 reportedly impacts the body’s use of stored fat for energy, improving metabolic flexibility. Its role in modulating fat metabolism provides an interesting research point for obesity and weight management studies.
-
Neuroprotective Effects: Preliminary studies suggest GW501516 may exhibit neuroprotective effects, which could be pivotal in researching neurological disorders such as Alzheimer’s and Parkinson’s.
-
Liver Function: GW501516 could be critical in researching non-alcoholic fatty liver disease (NAFLD), as it may help reduce inflammation and improve liver health.
-
Kidney Health: GW501516 may have benefits for kidney health by reducing inflammation and improving functions, offering a potential research outlet regarding chronic kidney diseases.
However, it is vital to note that though these are potential research benefits, the full impact of GW501516 remains an active area of research. Importantly, due to potential health risks associated with its use, GW501516 is not approved for use in humans by the FDA.
